ANGEL PINEDA: Open Payments
NPI 1952801243 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 40 payments from 14 companies in 2025. Trend: 2023 $264 · 2024 $1,122 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $264 |
| UCB, Inc. | 4 | $85 |
| Alexion Pharmaceuticals, Inc. | 2 | $63 |
| Medtronic, Inc. | 1 | $56 |
| Janssen Biotech, Inc. | 2 | $55 |
| Genentech USA, Inc. | 2 | $48 |
| Biogen, Inc. | 2 | $44 |
| ARGENX US, INC. | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| SK Life Science, Inc. | 1 | $32 |
Products named: UBRELVY, BOTOX, ULTOMIRIS, PERCEPT PC BRAINSENSE, Ocrevus Zunovo, Briviact, VUMERITY, QULIPTA.
Industry payments across TX — which companies pay providers there.
